Robert Goeltz
Finanzdirektor/CFO bei ARCUS BIOSCIENCES, INC.
Vermögen: 227 667 $ am 30.04.2024
Aktive Positionen von Robert Goeltz
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
| ARCUS BIOSCIENCES, INC. | Finanzdirektor/CFO | 01.08.2020 | - |
| Comptroller/Controller/Auditor | 01.08.2020 | 09.03.2023 |
Karriereverlauf von Robert Goeltz
Ehemalige bekannte Positionen von Robert Goeltz
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
| UNITY BIOTECHNOLOGY, INC. | Finanzdirektor/CFO | 01.09.2017 | 01.08.2020 |
| CYTOMX THERAPEUTICS, INC. | Finanzdirektor/CFO | 27.05.2015 | 15.05.2017 |
Onyx Pharmaceuticals, Inc.
 Onyx Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Onyx Pharmaceuticals, Inc. operates as a biopharmaceutical company. It engages in developing innovative therapies that target the molecular mechanisms that cause cancer. The company was founded by Frank McCormick in February 1992 and is headquartered in Thousand Oaks, CA. | Finanzdirektor/CFO | 01.10.2013 | 01.05.2015 |
Tularik, Inc.
 Tularik, Inc. Miscellaneous Commercial ServicesCommercial Services Tularik, Inc. is engaged in the discovery and development of a broad range of novel and superior orally available medicines that act through the regulation of gene expression. Tularik's scientific platform is focused on three therapeutic areas: cancer, inflammation and metabolic disease. The company was founded in 1991 and is headquartered in South San Francisco, CA. | Finanzdirektor/CFO | 01.07.2002 | 01.08.2004 |
Ausbildung von Robert Goeltz
| UCLA Anderson School of Management | Masters Business Admin |
| Goizueta Business School-Emory | Undergraduate Degree |
Statistik
International
| Vereinigte Staaten | 8 |
Operativ
| Director of Finance/CFO | 5 |
| Masters Business Admin | 1 |
| Undergraduate Degree | 1 |
Sektoral
| Health Technology | 5 |
| Consumer Services | 3 |
| Commercial Services | 2 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
| Börsennotierte Unternehmen | 3 |
|---|---|
| CYTOMX THERAPEUTICS, INC. | Health Technology |
| UNITY BIOTECHNOLOGY, INC. | Health Technology |
| ARCUS BIOSCIENCES, INC. | Health Technology |
| Private Unternehmen | 2 |
|---|---|
Onyx Pharmaceuticals, Inc.
Onyx Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Onyx Pharmaceuticals, Inc. operates as a biopharmaceutical company. It engages in developing innovative therapies that target the molecular mechanisms that cause cancer. The company was founded by Frank McCormick in February 1992 and is headquartered in Thousand Oaks, CA. | Health Technology |
Tularik, Inc.
Tularik, Inc. Miscellaneous Commercial ServicesCommercial Services Tularik, Inc. is engaged in the discovery and development of a broad range of novel and superior orally available medicines that act through the regulation of gene expression. Tularik's scientific platform is focused on three therapeutic areas: cancer, inflammation and metabolic disease. The company was founded in 1991 and is headquartered in South San Francisco, CA. | Commercial Services |
- Börse
- Insiders
- Robert Goeltz
- Erfahrung
